(S)-5-chloro-N-(3-cyclohexyl-1-oxo-1-(3-(trifluoromethyl)phenylamino)propan-2-yl)-2-hydroxybenzamide

ID: ALA2425561

PubChem CID: 72708208

Max Phase: Preclinical

Molecular Formula: C23H24ClF3N2O3

Molecular Weight: 468.90

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H](CC1CCCCC1)C(=O)Nc1cccc(C(F)(F)F)c1)c1cc(Cl)ccc1O

Standard InChI:  InChI=1S/C23H24ClF3N2O3/c24-16-9-10-20(30)18(13-16)21(31)29-19(11-14-5-2-1-3-6-14)22(32)28-17-8-4-7-15(12-17)23(25,26)27/h4,7-10,12-14,19,30H,1-3,5-6,11H2,(H,28,32)(H,29,31)/t19-/m0/s1

Standard InChI Key:  GEDNWCDPRLAKEC-IBGZPJMESA-N

Molfile:  

     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   27.9482  -18.8119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9470  -19.6314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6551  -20.0404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3647  -19.6309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3619  -18.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6533  -18.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0731  -20.0384    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0681  -18.3970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7773  -18.8029    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.0650  -17.5798    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.4835  -18.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1927  -18.7976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8989  -18.3863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1958  -19.6148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6081  -18.7923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6083  -19.6095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3168  -20.0154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0239  -19.6041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0182  -18.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3092  -18.3805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2404  -18.4034    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   31.4804  -17.5745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1866  -17.1632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7229  -18.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4336  -18.7723    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.7169  -17.5517    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   36.4269  -17.9534    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.8922  -17.5724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5963  -17.1647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5974  -16.3471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8883  -15.9390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1781  -16.3485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  1 21  1  0
 11 22  1  1
 22 23  1  0
 19 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 23 28  1  0
 23 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
M  END

Associated Targets(Human)

G-361 (890 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOS (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.90Molecular Weight (Monoisotopic): 468.1428AlogP: 5.77#Rotatable Bonds: 6
Polar Surface Area: 78.43Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.66CX Basic pKa: CX LogP: 6.48CX LogD: 6.29
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.50Np Likeness Score: -1.08

References

1. Imramovský A, Jorda R, Pauk K, Rezníčková E, Dušek J, Hanusek J, Kryštof V..  (2013)  Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines.,  68  [PMID:23981532] [10.1016/j.ejmech.2013.08.009]

Source